$AUSI
AURA SYSTEMS INC Stock $ausi

$ausi Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024049745 Filed on June 04, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$47.00K	$56.00K	$56.00K
YoY Change	370.0%	8932.26%	-21.13%
Cost Of Revenue	-$47.00K	$70.00K	$193.0K
YoY Change	-413.33%	117.59%	119.32%
Gross Profit		-$14.00K	-$137.0K
YoY Change		-55.63%	705.88%
Gross Profit Margin		-25.0%	-244.64%
Selling, General & Admin	$374.0K	$1.873M	$1.873M
YoY Change	-26.38%	208.3%	-28.95%
% of Gross Profit
Research & Development	$310.0K	$750.0K	$750.0K
YoY Change	49.76%	256.58%	-11.76%
% of Gross Profit
Depreciation & Amortization	$25.00K	$26.00K	$105.0K
YoY Change	-3.85%	25.73%	34.62%
% of Gross Profit
Operating Expenses	$684.0K	$2.623M	$2.623M
YoY Change	-4.34%	220.72%	-24.76%
Operating Profit	-$684.0K	-$2.637M	-$2.760M
YoY Change	-5.0%	210.45%	-21.21%
Interest Expense	$275.0K	-$1.456M	$1.465M
YoY Change	-35.75%	-7113.49%	101.51%
% of Operating Profit
Other Income/Expense, Net	$2.000K	$441.0K
YoY Change	-71.43%	44000.0%
Pretax Income	-$15.26M	-$4.216M	-$4.216M
YoY Change	1237.42%	409.4%	23.64%
Income Tax
% Of Pretax Income
Net Earnings	-$15.26M	-$4.216M	-$4.200M
YoY Change	1237.25%	409.4%	23.17%
Net Earnings / Revenue	-32463.83%	-7528.57%	-7500.0%
Basic Earnings Per Share	-$0.14		-$0.04
Diluted Earnings Per Share	-$0.14	-$0.04	-$0.04
COMMON SHARES
Basic Shares Outstanding	109.0M shares	102.0M shares	99.38M shares
Diluted Shares Outstanding	106.1M shares		99.38M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$297.0K	$124.0K	$124.0K
YoY Change	494.0%	726.67%	726.67%
Cash & Equivalents	$297.0K	$124.0K	$124.0K
Short-Term Investments
Other Short-Term Assets	$140.0K	$175.0K	$175.0K
YoY Change	8.53%	23.24%	23.24%
Inventory		$20.00K	$20.00K
Prepaid Expenses
Receivables	$15.00K
Other Receivables	$0.00
Total Short-Term Assets	$452.0K	$319.0K	$319.0K
YoY Change	32.55%	2.24%	2.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$710.0K	$378.0K	$985.0K
YoY Change	55.02%	-18.0%	-22.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$160.0K	$160.0K	$160.0K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$1.429M	$1.145M	$1.145M
YoY Change	3.18%	-20.32%	-20.32%
TOTAL ASSETS
Total Short-Term Assets	$452.0K	$319.0K	$319.0K
Total Long-Term Assets	$1.429M	$1.145M	$1.145M
Total Assets	$1.881M	$1.464M	$1.464M
YoY Change	8.98%	-16.3%	-16.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.407M	$2.625M	$2.625M
YoY Change	-12.85%	13.29%	13.29%
Accrued Expenses	$1.948M	$2.598M	$2.836M
YoY Change	8.58%	41.97%	39.22%
Deferred Revenue
YoY Change
Short-Term Debt	$5.783M	$4.528M	$4.528M
YoY Change
Long-Term Debt Due	$945.0K	$4.751M	$4.751M
YoY Change	-89.74%	-48.41%	-48.41%
Total Short-Term Liabilities	$28.70M	$15.19M	$15.19M
YoY Change	98.88%	8.28%	8.28%
LONG-TERM LIABILITIES
Long-Term Debt	$8.449M	$7.374M	$7.374M
YoY Change	16.73%	0.72%	0.72%
Other Long-Term Liabilities	$358.0K	$423.0K	$423.0K
YoY Change	-40.63%	-35.91%	-35.91%
Total Long-Term Liabilities	$8.807M	$7.797M	$7.797M
YoY Change	12.32%	-2.31%	-2.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.70M	$15.19M	$15.19M
Total Long-Term Liabilities	$8.807M	$7.797M	$7.797M
Total Liabilities	$37.51M	$22.98M	$22.98M
YoY Change	68.41%	4.44%	4.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$494.2M	-$479.0M
YoY Change	3.85%	0.89%
Common Stock	$458.6M	$457.5M
YoY Change	5095688.89%	5082900.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$35.63M	-$21.50M	-$21.52M
YoY Change
Total Liabilities & Shareholders Equity	$1.881M	$1.464M	$1.464M
YoY Change	8.98%	-16.3%	-16.3%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	-$15.26M	-$4.216M	-$4.200M
YoY Change	1237.25%	409.4%	23.17%
Depreciation, Depletion And Amortization	$25.00K	$26.00K	$105.0K
YoY Change	-3.85%	25.73%	34.62%
Cash From Operating Activities	-$784.0K	-$817.0K	-$3.000M
YoY Change	-1.63%	-5.99%	-3.94%
INVESTING ACTIVITIES
Capital Expenditures	$36.00K	-$1.000K	$22.00K
YoY Change	3500.0%	426.32%	-59.26%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$36.00K	$1.000K	-$22.00K
YoY Change	3500.0%	426.32%	-59.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.943M
YoY Change			-10.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$993.0K	895.0K	$3.126M
YoY Change	19.21%	37.66%	2.76%
NET CHANGE
Cash From Operating Activities	-$784.0K	-817.0K	-$3.000M
Cash From Investing Activities	-$36.00K	1.000K	-22.00K
Cash From Financing Activities	$993.0K	895.0K	$3.126M
Net Change In Cash	$173.0K	79.00K	$126.0K
YoY Change	380.56%	-136.13%	-255.56%
FREE CASH FLOW
Cash From Operating Activities	-$784.0K	-$817.0K	-$3.000M
Capital Expenditures	$36.00K	-$1.000K	$22.00K
Free Cash Flow	-$820.0K	-$816.0K	-$3.022M
YoY Change	2.76%	-6.08%	-4.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88947803	shares
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-02-29
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	0-17249
CY2024	dei	Entity Registrant Name EntityRegistrantName	AURA SYSTEMS, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4106894
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	20431 North Sea
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Lake Forest
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92630
CY2024	dei	City Area Code CityAreaCode	(310)
CY2024	dei	Local Phone Number LocalPhoneNumber	643-5300
CY2024	dei	Security12b Title Security12bTitle	None
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	19201000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	109047248	shares
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	dei	Auditor Firm AuditorFirmId	572
CY2024	dei	Auditor Name AuditorName	Weinberg & Company, P.A
CY2024	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	124000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	20000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	155000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	175000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	142000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	319000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	312000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	378000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	461000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	607000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	816000	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	160000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	160000	usd
CY2024Q1	us-gaap	Assets Assets	1464000	usd
CY2023Q1	us-gaap	Assets Assets	1749000	usd
CY2024Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	223000	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	226000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2625000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2758000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2076000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1145000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2598000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1471000	usd
CY2024Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	447000	usd
CY2023Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	454000	usd
CY2024Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	119000	usd
CY2023Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	92000	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1508000	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1403000	usd
CY2024Q1	ausi	Convertible Note Payablesrelated Party Past Due ConvertibleNotePayablesrelatedPartyPastDue	3020000	usd
CY2023Q1	ausi	Convertible Note Payablesrelated Party Past Due ConvertibleNotePayablesrelatedPartyPastDue	3000000	usd
CY2024Q1	ausi	Notes Payablerelated Parties Past Due NotesPayablerelatedPartiesPastDue	700000	usd
CY2023Q1	ausi	Notes Payablerelated Parties Past Due NotesPayablerelatedPartiesPastDue	700000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	238000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	207000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	9000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15187000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14026000	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	286000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	256000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	423000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	660000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	22984000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	22007000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	104591648	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104591648	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	94648346	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94648346	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	457460000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	454507000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-478990000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-474774000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-21520000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-20258000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1464000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1749000	usd
CY2024	us-gaap	Revenues Revenues	56000	usd
CY2023	us-gaap	Revenues Revenues	71000	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	193000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	88000	usd
CY2024	us-gaap	Gross Profit GrossProfit	-137000	usd
CY2023	us-gaap	Gross Profit GrossProfit	-17000	usd
CY2024	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	151000	usd
CY2023	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	150000	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	750000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	850000	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1873000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2636000	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	2623000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	3486000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-2760000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3503000	usd
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1064000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	545000	usd
CY2024	us-gaap	Interest Expense InterestExpense	1465000	usd
CY2023	us-gaap	Interest Expense InterestExpense	727000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	237000	usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-582000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-4216000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3410000	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99379779	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88947803	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-21219000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3270000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	1051000	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	50000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3410000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-20258000	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2943000	usd
CY2024	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	6000	usd
CY2024	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-4216000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-21520000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-4216000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3410000	usd
CY2024	us-gaap	Depreciation Depreciation	105000	usd
CY2023	us-gaap	Depreciation Depreciation	78000	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	123000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	4000	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	237000	usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-582000	usd
CY2024	ausi	Common Stock Issued For Services CommonStockIssuedForServices	6000	usd
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4000	usd
CY2023	ausi	Common Stock Warrants Issued For Services CommonStockWarrantsIssuedForServices	50000	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	33000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-114000	usd
CY2024	ausi	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-209000	usd
CY2023	ausi	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-184000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-133000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	364000	usd
CY2024	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	1150000	usd
CY2023	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	492000	usd
CY2024	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-7000	usd
CY2023	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	14000	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-206000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-179000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2995000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3123000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54000	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2943000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3270000	usd
CY2024	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	281000	usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	98000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	228000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3126000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3042000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	109000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-135000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	124000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15000	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	185000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	166000	usd
CY2024	ausi	Fair Value Of Warrants Issued For Note Payable FairValueOfWarrantsIssuedForNotePayable	5000	usd
CY2023	ausi	Fair Value Of Warrants Issued For Note Settlement FairValueOfWarrantsIssuedForNoteSettlement	1051000	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – ORGANIZATION AND OPERATIONS</b></p> <p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Aura Systems, Inc., (“Aura”, “We” or the “Company”) a Delaware corporation, is engaged in the development, commercialization, and sale of products, systems, and components, using its patented and proprietary electromagnetic technology. Aura develops and sells AuraGen<sup>® </sup>axial flux mobile induction power systems to the industrial, commercial, and defense mobile power generation markets.</p> <p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Going Concern</b></p> <p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. In accordance with Accounting Standards Codification (“ASC”) 205-40, <i>Going Concern</i>, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. During the fiscal year ended February 29, 2024, the Company incurred a net loss of $4.2 million, used cash in operating activities of $3 million, and at February 29, 2024, had a stockholders deficit of $21.5 million. In addition, at February 29, 2024, notes payable and related accrued interest with an aggregate balance of $6.7 million have reached maturity and are past due. These factors raise substantial doubts about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subsequent to February 29, 2024, the Company issued 4,455,600 shares of common stock in exchange for cash proceeds of $1.1 million. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. During the next twelve months we intend to continue to attempt to increase the Company’s sale of our AuraGen<sup>®</sup>/VIPER products both domestically and internationally and to add to our existing management team. In addition, we plan to continue to rebuild the engineering and sales teams, and to the extent appropriate, utilize third party contractors to support the operation. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stockholders, in the case of equity financing. In the event the Company is unable to generate profits and is unable to obtain financing for its working capital requirements, it may have to curtail its business further or cease business altogether.</p>
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-4200000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-21500000	usd
CY2024Q1	ausi	Aggregate Balance Of Notes Payable AggregateBalanceOfNotesPayable	6700000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Significant estimates include assumptions made for inventory reserve, impairment testing of long-lived assets, the realizability of deferred tax assets and the related valuation allowance, assumptions used in valuing derivative liabilities, notes payable, assumptions used in valuing share-based compensation, and accruals for potential liabilities. Amounts could materially change in the future.</p><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	1	pure
CY2024	us-gaap	Revenues Revenues	56000	usd
CY2023	us-gaap	Revenues Revenues	71000	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate	0.02	pure
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	123000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	4000	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit and Other Risks</b></p><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. Cash is deposited with a limited number of financial institutions. The balances held at any one financial institution at times may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits of up to $250. We have not experienced any losses in such accounts and believe we are not exposed to any significant risk on cash and cash equivalents.</p><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended February 29, 2024, one customer accounted for 55% and one customer accounted for 12% of revenues. During the year ended February 28, 2023, one customer accounted for 55% and one customer accounted for 10% of revenues.</p><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of February 29, 2024, four vendors accounted for 42%, 11%, 11% and 10% of accounts payable. As of February 28, 2023, four vendors accounted for 38%, 13%, 10% and 10% of accounts payable.</p><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	750000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	850000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	9000	usd
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	9000	usd
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Reclassifications</span></p><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain February 28, 2023 balances have been reclassified to conform with the February 29, 2024 presentation. In presenting the Company’s balance sheet at February 28, 2023, the Company originally presented accrued interest of $1,389 and accrued payroll and other expenses of $441, totaling $1,830 as a separate line item called Accrued Expenses. In addition, $82 of accrued interest was included in notes payable-related parties, current portion. In presenting the Company’s balance sheet at February 29, 2024, the Company has reclassified the balance of accrued interest of $1,471 as a separate line item, and the balance of accrued payroll and other expenses of $441 as part of accounts payable and accrued expense and reduced notes payable-related parties, current portion by $82. </p><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	1389000	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	441000	usd
CY2023Q1	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	1830000	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	1471000	usd
CY2024Q1	us-gaap	Other Expenses OtherExpenses	441000	usd
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12457109	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12264808	shares
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	13000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	114000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	6000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	22000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	19000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	20000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	155000	usd
CY2024Q1	ausi	Prepaid Annual Software Licenses PrepaidAnnualSoftwareLicenses	158000	usd
CY2023Q1	ausi	Prepaid Annual Software Licenses PrepaidAnnualSoftwareLicenses	92000	usd
CY2024Q1	us-gaap	Advances To Affiliate AdvancesToAffiliate	9000	usd
CY2023Q1	us-gaap	Advances To Affiliate AdvancesToAffiliate	8000	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	2000	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	11000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	6000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	31000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	175000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	142000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	576000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	554000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	198000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	93000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	378000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	461000	usd
CY2024	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	105000	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	78000	usd
CY2024Q1	ausi	Convertible Notes Payable Current Gross ConvertibleNotesPayableCurrentGross	1509000	usd
CY2023Q1	ausi	Convertible Notes Payable Current Gross ConvertibleNotesPayableCurrentGross	1403000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1000	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1508000	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1403000	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1508000	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1403000	usd
CY2024Q1	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.05	pure
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1403000	usd
CY2024	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	106000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	50000	shares
CY2024Q1	ausi	Convertible Notes Payable Current Gross ConvertibleNotesPayableCurrentGross	1509000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1000	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1508000	usd
CY2024Q1	us-gaap	Convertible Debt ConvertibleDebt	3020000	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	3000000	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	3020000	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	3000000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	405000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	348000	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	119000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	92000	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	286000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	256000	usd
CY2022Q1	ausi	Down Payment Amount DownPaymentAmount	41000	usd
CY2024Q1	us-gaap	Notes And Loans Payable NotesAndLoansPayable	106000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	139000	usd
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.10	pure
CY2023Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.10	pure
CY2024Q1	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	1051000	usd
CY2024Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.06	pure
CY2022Q2	ausi	Installment Paid InstallmentPaid	150000	usd
CY2022Q2	ausi	Installment Outstanding InstallmentOutstanding	2850000	usd
CY2022Q2	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.06	pure
CY2024	ausi	Installment Paid InstallmentPaid	1000000	usd
CY2024	ausi	Installment Due InstallmentDue	3850	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	23000	usd
CY2024Q4	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	1850	usd
CY2022Q1	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	10	day
CY2022Q1	ausi	Percentage Of Remit Cash Proceeds Equal To Revenues And Debt Or Equity PercentageOfRemitCashProceedsEqualToRevenuesAndDebtOrEquity	0.20	pure
CY2024Q1	ausi	Required To Payment RequiredToPayment	0.20	pure
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.85
CY2022Q1	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.5
CY2014Q2	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.10	pure
CY2024Q1	ausi	Accrued Interestconvertible Notes Payablepast Due AccruedInterestconvertibleNotesPayablepastDue	425000	usd
CY2023Q1	ausi	Accrued Interestconvertible Notes Payablepast Due AccruedInterestconvertibleNotesPayablepastDue	354000	usd
CY2024Q1	ausi	Accrued Interest Convertible Notes Payable Related Party AccruedInterestConvertibleNotesPayableRelatedParty	863000	usd
CY2023Q1	ausi	Accrued Interest Convertible Notes Payable Related Party AccruedInterestConvertibleNotesPayableRelatedParty	713000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	1288000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	363000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	22000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	41000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2598000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1471000	usd
CY2021Q1	us-gaap	Area Of Land AreaOfLand	18	sqft
CY2024	us-gaap	Payments For Rent PaymentsForRent	22000	usd
CY2024	ausi	Lease Rent Percentage LeaseRentPercentage	0.03	pure
CY2024Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	285000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	279000	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	285000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	274000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	607000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	238000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	423000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	661000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	291000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	299000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	155000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	745000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	84000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	661000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	ausi	Common Stock For Services CommonStockForServices	6	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4800834	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.4
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3451664	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.82
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	4687734	shares
CY2023	ausi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue	1.4
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3564764	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.86
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	60000	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.5
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	103100	shares
CY2024	ausi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue	1.4
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3521664	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.83
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.5
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.84
CY2024Q1	us-gaap	Share Price SharePrice	0.164
CY2023Q1	us-gaap	Share Price SharePrice	0.341
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.60	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.246	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.049	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0204	pure
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y6M
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y10M24D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q2	ausi	Payment Of Initial Amount PaymentOfInitialAmount	150000000	usd
CY2024Q1	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	120000000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Domestic EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Domestic EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic	0.21	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0.07	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0.07	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.28	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.28	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0	pure
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39374000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	42141000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	39374000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	42141000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39374000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	42141000	usd
CY2024	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2700000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2700000	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	144700000	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	102500000	usd
CY2024Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	5600	usd
CY2024Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	213000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	141000	usd
CY2019Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	27500000	usd
CY2024Q1	us-gaap	Cash Cash	1100000	usd
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
CY2024	dei	Security Exchange Name SecurityExchangeName	NONE
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99379779	shares
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023	ausi	Common Stock Issued For Services CommonStockIssuedForServices		usd
CY2024	ausi	Common Stock Warrants Issued For Services CommonStockWarrantsIssuedForServices		usd
CY2024	ausi	Fair Value Of Warrants Issued For Note Settlement FairValueOfWarrantsIssuedForNoteSettlement		usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure		usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2024Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0000826253
CY2024	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001213900-24-049745-index-headers.html	Edgar Link	pending
0001213900-24-049745-index.html	Edgar Link	pending
0001213900-24-049745.txt	Edgar Link	pending
0001213900-24-049745-xbrl.zip	Edgar Link	pending
ausi-20240229.xsd	Edgar Link	pending
ea0207082-10k_aurasystems.htm	Edgar Link	pending
ea020708201ex31-1_aura.htm	Edgar Link	pending
ea020708201ex31-2_aura.htm	Edgar Link	pending
ea020708201ex32-1_aura.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
ausi-20240229_lab.xml	Edgar Link	unprocessable
ausi-20240229_def.xml	Edgar Link	unprocessable
ausi-20240229_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0207082-10k_aurasystems_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ausi-20240229_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AUSI
AURA SYSTEMS INC Stock $ausi

2024 Q2 Form 10-K Financial Statement

#000121390024049745 Filed on June 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUSI AURA SYSTEMS INC Stock $ausi

2024 Q2 Form 10-K Financial Statement

#000121390024049745 Filed on June 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUSI
AURA SYSTEMS INC Stock $ausi